2025-04-01 09:52:51.AIbase.16.8k
Isomorphic Labs, DeepMind Spin-off, Secures $600 Million to Advance AI Drug Discovery
Isomorphic Labs, a platform focused on AI-powered drug discovery, founded in 2021 as a spin-off from Google's DeepMind, has secured $600 million in Series A funding led by Thrive Capital, with participation from GV and existing investor Alphabet (Google's parent company). This funding will accelerate the further development of Isomorphic's AI drug design engine and support the company's R&D efforts.
